Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced new positive efficacy, safety and ...

The long-term safety of TEV-‘749 and incidence of PDSS are also being evaluated in the SOLARIS open-label study (Period 2), with safety data topline readout expected in the first half of 2025.

A team of US-based researchers has concluded that high-dose vitamin D3 does not provide any additional benefit for patients ...

A medication that is currently used for chronic kidney disease in patients with type 2 diabetes has been found to reduce the risk of worsening heart failure and cardiovascular death in certain ...

If you’re taking other medication, mild flares will eventually go away on their own. If they aren’t bothering you, you don't need to treat them. If the symptoms of your flares worsen ...

Ouverte en juin, la clinique Vivago propose des soins de santé mentale à la population, et tout particulièrement aux jeunes personnes issues de communautés marginalisées : LGBTQ+, Premières ...